Patent ID: 8008346

Claim:
A method to treat a lymphoma in an individual in need thereof said method comprising: administering to said individual a chemotherapeutic agent selected from the group consisting of doxorubicin, daunorubicin, cyclophosphamide, methotrexate, paclitaxel and alkylating agents, and a composition comprising an effective amount of a compound of formula I, or II, and a pharmaceutically acceptable carrier, wherein R 1 , R 2 and R 3 are independently a hydrogen atom, a halogen atom, an oxygen atom of a ketone group, —OR 4 , —C(O)H, —CO 2 H, —C(O)R 18 , —NR 11 R 12 , —SH, C 1 -C 10 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 8 cycloalkyl, C 4 -C 10 cycloalkenyl, —(CH 2 ), C 1 -C 10 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 8 cycloalkyl, C 4 -C 10 cycloalkenyl, C 6 -C 12 aralkyl, —C(O)H, or a protected hydroxyl group, R 4 and R 18 are a hydrogen atom alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 8 cycloalkyl, C 4 -C 10 cycloalkenyl, C 6 -C 12 aralkyl, —C(O)H, or a protecting group for a hydroxyl group; R 11 and R 12 are independently hydrogen, C 1 -C 10 alkyl, C 6 -C 12 aralkyl.